Japan Agency for Medical Research and Development (AMED) leads the Initiative on Rare and Undiagnosed Diseases (IRUD) program. The program provides patients across Japan suffering from undiagnosed diseases with a diagnostic strategy that involves genetic analysis
View this resource Bookmark this resource
AMED Clinical Innovation network – Diseases-related Registries
Published by IRDiRC
Research and Drug DevelopmentClinical DevelopmentPatient RegistryAgency For Medical Research and DevelopmentJapanInitiative on Rare DiseasesClinical Innovation NetworkCinical Trial
